Article
Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes.
European journal of cancer (Oxford, England : 1990) - 1 May 2014
Yang Ching-Yao, Lin Mong-Wei, Chang Yih-Leong, Wu Chen-Tu, Yang Pan-Chyr
Abstract excerpt
BACKGROUND: Programmed cell death-ligand 1 (PD-L1) is expressed in a group of cancers that may be suitable targets for specific immunotherapy. This study investigated the expression of PD-L1 in surgically resected stage I adenocarcinomas and correlated this with known major driver mutations and clinical outcomes. MATERIALS AND METHODS: One hundred and sixty-three patients with surgically resected stage I...
Topics
- Adenocarcinoma
- Adult
- Aged
- Aged, 80 and over
- Anaplastic Lymphoma Kinase
- B7-H1 Antigen
- Carcinoma, Non-Small-Cell Lung
- ErbB Receptors
- Female
- Humans
- Lung Neoplasms
